Dielectrically Modulated Double Gate Single Cavity InGaAs/GaAsSb HTFET (DMDG–SC–InGaAs/GaAsSb HTFET) is a novel label-free, nanocavity embedded dielectrically modulated heterostructure TFET-based biosensor. The III-V heterostructure (InGaAs/GaAsSb) has a high ION/IOFF ratio, better gate control, and higher tunnelling probability. In order to effectively reduce ambipolarity, asymmetrical doping is used at the p+ source and n+ drain, along with gate work function engineering. The stacked layers of HfO2/SiO2 gate oxide help to reduce the fringing electric field. The suggested device utilizes a dielectrically controlled technique to achieve biomolecule conjugation. This is done by etching a single nanogap cavity in the gate dielectric material towards the source end. An evaluation of the dielectric constants [K = 2.1, 2.63, 3.30, 6.3, and 12] of neutral and charged biomolecules compared to air [k = 1] is essential to determine the sensitivity of biosensors in an arid environment. The transconductance-to-current ratio (gm/Ids), switching ratio (ION/IOFF), and threshold voltage are the performance metrics used to evaluate the device sensitivity. The DM-DG–SC–InGaAs/GaAsSb HTFETpromises to be very sensitive while using less power during the detection process. It also shows that it could be a good choice for label-free biosensor applications.